Article Versions Notes

Faisal MM, Gomaa E, Attia MS, Abdelnaby RM, Ibrahim AE, Al-Harrasi A, El Deeb S, Al Ashmawy AZG. Albumin-Based Nanoparticles with Factorial Design as a Promising Approach for Remodeled Repaglinide: Evidence from In Silico, In Vitro, and In Vivo Evaluations. Pharmaceutics. 2025; 17(3):350. https://doi.org/10.3390/pharmaceutics17030350

Faisal, Mennatullah M., Eman Gomaa, Mohamed S. Attia, Rana M. Abdelnaby, Adel Ehab Ibrahim, Ahmed Al-Harrasi, Sami El Deeb, and Al Zahraa G. Al Ashmawy. 2025. "Albumin-Based Nanoparticles with Factorial Design as a Promising Approach for Remodeled Repaglinide: Evidence from In Silico, In Vitro, and In Vivo Evaluations" Pharmaceutics 17, no. 3: 350. https://doi.org/10.3390/pharmaceutics17030350

Faisal, M. M., Gomaa, E., Attia, M. S., Abdelnaby, R. M., Ibrahim, A. E., Al-Harrasi, A., El Deeb, S., & Al Ashmawy, A. Z. G. (2025). Albumin-Based Nanoparticles with Factorial Design as a Promising Approach for Remodeled Repaglinide: Evidence from In Silico, In Vitro, and In Vivo Evaluations. Pharmaceutics, 17(3), 350. https://doi.org/10.3390/pharmaceutics17030350